CAR-T therapy harnesses a patient’s own T cells, reprogramming them to attack cancer with precision. This groundbreaking immunotherapy is transforming treatment outcomes for leukemia, lymphoma, and other cancers, offering hope where conventional therapies may fall short. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/